GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF

GSK plc

Financials through fiscal 2025, year ended Dec 31, 2025

$49.46−0.05 (-0.10%)

Close on Oct 19, 2026

GSK statistics

Financials through Dec 31, 2025, price-based ratios appear once a share price is available

Valuation

Market Cap	£80.67B
Enterprise Value	£94.57B
PE Ratio	13.47
PS Ratio	2.47
PB Ratio	4.93
P/FCF Ratio	12.62
P/OCF Ratio	10.42

Enterprise value

EV / Sales	2.90
EV / EBITDA	9.23
EV / EBIT	11.92
EV / FCF	14.79

Income (trailing twelve months)

Revenue	£32.67B
Gross Profit	£23.65B
Operating Income	£7.93B
Pretax Income	£7.40B
Net Income	£5.72B
EBITDA	£10.25B
EPS (Diluted)	1.39 GBP

Margins

Gross Margin	72.4%
Operating Margin	24.3%
Pretax Margin	22.7%
Profit Margin	17.5%
EBITDA Margin	31.4%
FCF Margin	19.6%

Returns

Return on Equity (ROE)	38.0%
Return on Assets (ROA)	9.48%
Return on Invested Capital (ROIC)	23.4%
Return on Capital Employed (ROCE)	20.0%

Growth

Revenue Growth (YoY)	4.11%
Net Income Growth (YoY)	122.0%
EPS Growth (YoY)	123.2%
FCF Growth (YoY)	24.0%
Revenue Growth (3Y CAGR)	3.66%
Revenue Growth (5Y CAGR)	6.05%
EPS Growth (3Y CAGR)	-27.6%
EPS Growth (5Y CAGR)	-0.54%

Balance sheet

Cash & Short-Term Investments	£3.40B
Total Debt	£17.72B
Net Cash (Debt)	-£14.32B
Net Cash Per Share	-3.32 GBP
Equity (Book Value)	£16.38B
Book Value Per Share	3.79 GBP
Tangible Book Value	-£7.39B
Working Capital	-£3.88B

Financial position

Current Ratio	0.82
Quick Ratio	0.51
Debt / Equity	1.08
Debt / EBITDA	1.73
Debt / FCF	2.77
Net Debt / EBITDA	1.40
Interest Coverage	11.32

Cash flow (trailing twelve months)

Operating Cash Flow	£7.74B
Capital Expenditures	-£1.35B
Free Cash Flow	£6.39B
FCF Per Share	1.48 GBP

Efficiency

Asset Turnover	0.54
Inventory Turnover	1.56
Revenue Per Employee	£65.33K
Profits Per Employee	£11.43K
Employee Count	500,000

Dividends and yields

Earnings Yield	7.09%
FCF Yield	7.92%
Buyback Yield	1.69%
Shareholder Yield	1.69%
Payout Ratio	44.9%
FCF Payout Ratio	40.1%

Shares Outstanding	4,315,450,000
Shares Change (YoY)	-0.60%
Float	4,313,460,000
Shares Held by Insiders	0.05%
Shares Held by Institutions	8.03%

Taxes

Income Tax	£1.11B
Effective Tax Rate	15.0%

Scores

Graham Number	10.89 GBP
Graham Upside	-41.8%
Altman Z-Score	2.19
Piotroski F-Score	9
Beneish M-Score	-2.46

Calculated by StockData from GSK's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.